Community/Retail

Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses challenges associated with the integration of information technologies into pharmacy practice.

Pharmacy students attending the University of Southern California (USC) School of Pharmacy don't need to worry about being adequately prepared to work in the field after graduation.

Citing its wide range of commuter benefits to employees, NACDS was named one of the nation's "Best Workplaces for Commuters" by the National Center for Transit Research (NCTR) of the University of South Florida and the U.S. Environmental Protection Agency.

Techs unsure of their state's laws can consult this reference guide, which explains how to become licensed as a pharmacy technician in each state.

Adults who get immunized against influenza are protecting not only themselves, but also their elderly peers.

Pharmacy marketing leader Nicolle McClure, of GRX Marketing, and David Pope, co-founder of Creative Pharmacist, discuss how to leverage modern technologies, #DigitalHealth, and patient engagement marketing strategies to reinvent the business of pharmacy through innovation.

While NSAIDs are effective in treating various pain conditions, their long-term risks frequently preclude safe chronic use in many patients.

Pharmacists need to bring more value to the health care table than functions that can be performed by robots.

It is easy for pharmacists to forget that most patients don't understand the medical terminology and jargon they use every day.

How workers react to stress ultimately makes or breaks a flight or patient care plan.

A federal district court has dismissed a lawsuit brought by pharmacy benefits managers (PBMs) against drug pricing transparency legislation in Iowa.

In order to innovate, a systematic process must be followed.

Amgen and Dezima have entered into a definitive acquisition agreement under which Amgen will acquire Dezima, a privately-held,Netherlands-based biotechnology company focused on developing innovative treatments for dyslipidemia.

Sanofi has announced that its Corporate Social Responsibility (CSR) performance has been recognized in the Dow Jones Sustainability Indices.

Amgen and Xencor have entered into a research and license agreement to develop and commercialize novel therapeutics in the areas of cancer immunotherapy and inflammation.

Allergan and the US Women's Health Alliance (USWHA) have announced an agreement to make Liletta available to patients across 26 Alliance health care groups nationwide.

The FDA could soon approve a pediatric use for Teva's albuterol sulfate inhalation powder (ProAir RespiClick).

A 90-year-old man resorted to bribery and harassment to get his hands on hydrocodone at a Walmart pharmacy in Chattanooga, Tennessee.

Bruce A. Berger, PhD, president of Berger Consulting LLC, discusses how motivational interviewing plays into value-based care.

Doug Long, vice president of industry relations at IMS Health, discusses if health care providers will be hesitant to prescribe biosimilars.

A museum in Pennsylvania is celebrating what has been touted as the oldest, continuously operating drugstore in the country.

The BRIDGE trial proposed that foregoing bridging entirely would be non-inferior to bridge therapy with dalteparin in patients taking warfarin for atrial fibrillation.

There is a lot of gray area where independent MTM consultants are concerned.

What does opiate failure look like in the primary care setting, and why isn't it recognized more often?

If medications had personalities, take this quiz to find out what yours would be.

Approximately 65% of individuals undergoing chemotherapy will experience chemotherapy-induced hair loss, which is usually temporary and completely reversible when therapy ends.

Cardinal Health has announced the launch of the Hospital Quality at Home brand, a new line of hospital-quality products available over the counter to help loved ones and caregivers transition care from the hospital to home.

Pharmacists in California could soon be required to provide prescription drug labels in 5 languages besides English under a law unanimously passed by state lawmakers.

Daiichi Sankyo has signed an exclusive licensing agreement with Translational Sciences to develop and commercialize its novel thrombus dissolving agent, TS23, which is currently undergoing Phase I clinical trials.

Clinicians would like to have better information about treatment options for bipolar depression, but clinical trials of any length are scarce.